FDA cosmetics

July monthly roundup

EU News Updated European Cosmetic Ingredients Glossary Becomes Mandatory on 30 July 2026 The European Glossary of Common Ingredient Names was published in July 2025 and will become mandatory on30 July 2026. It provides the official INCI-style names that must appear in ingredient lists on cosmetic product labels. What this means for brands: Formaldehyde Releaser Labeling: New EU […]

July monthly roundup Read More »

June monthly roundup

EU PPWR — Packaging & Packaging Waste Regulation starts to bite The EU’s new Packaging and Packaging Waste Regulation reshapes how cosmetic packaging is designed, composed, labelled and recycled. It applies directly in every Member State, so requirements are harmonised across the bloc. Cosmetics is among the most exposed sectors given the variety of formats

June monthly roundup Read More »

May monthly roundup

EU 8 New Cosmetic Substances Fully Restricted Since May 1, 2026 Regulation (EU) 2026/78 has officially entered into full application, introducing restrictions and prohibitions for 18 substances newly classified as CMRs under the CLP Regulation. Among the substances now prohibited in cosmetics are: At the same time, substances such as Hexyl Salicylate and silver powder

May monthly roundup Read More »

March monthly roundup

EU PFAS in Europe: Restriction Process Enters a Critical Phase The proposed EU-wide restriction on PFAS is moving forward, with ECHA’s RAC opinion now adopted and SEAC’s draft opinion open for consultation until 25 May 2026. ECHA has framed this as the final opportunity for stakeholders to comment before the proposal moves toward the European Commission.  Why it matters Key takeaway

March monthly roundup Read More »

February monthly roundup

EU Prostaglandin Analogues: Final Opinion of the SCCS The Scientific Committee on Consumer Safety (SCCS) has published the final Opinion on prostaglandin analogues used in cosmetic products (notably lash and brow serums) on 10 February 2026. In 2022, SCCS was unable to conclude on safety due to insufficient data. Following new industry submissions, the Committee has now

February monthly roundup Read More »

January monthly roundup

EU Omnibus Act VIII: new CMR bans and restrictions published The European Union has formally published Regulation (EU) 2026/78, the eighth annual “CMR Omnibus” regulation amending the EU Cosmetics Regulation. The text transposes the 22nd ATP of the CLP Regulation into cosmetic law and introduces extensive changes to Annexes II, III, IV and V. Key regulatory changes include: Timeline

January monthly roundup Read More »

December monthly roundup

EU Titanium Dioxide: EU Formally Confirms End of Carcinogenic Classification On 10 December 2025, the European Commission confirmed in the Official Journal the annulment of the harmonised Carcinogen Category 2 classification for titanium dioxide (TiO₂) under the CLP Regulation. This follows the Court of Justice of the European Union (CJEU) decision of 1 August 2025, which upheld the annulment of part of Delegated Regulation (EU) 2020/217. As a

December monthly roundup Read More »

September regulatory roundup

EU News EU Issues Draft Regulation on Cosmetic Ingredients: New Classifications May Lead to Restrictions On 25 September 2024, the European Union issued a draft Regulation representing the 23rd Adaptation to Technical and Scientific Progress (ATP) under the Classification, Labelling, and Packaging (CLP) Regulation. This draft focuses on classifying eight chemical substances, several of which are widely used in cosmetics and other sectors.

September regulatory roundup Read More »

Cosmetics Direct FDA Portal for Cosmetic Product Listing is Live

The U.S. Food and Drug Administration (FDA) has launched Cosmetics Direct on 18 December! Cosmetics Direct is an electronic portal for registering and listing cosmetic product facilities and products. This initiative, mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), aims to streamline the submission process for the industry. Cosmetics Direct provides a

Cosmetics Direct FDA Portal for Cosmetic Product Listing is Live Read More »

FDA’s New Reporting Standards for Cosmetic Adverse Events

The FDA has announced significant updates for reporting severe adverse events in cosmetics, as required by the 2022 Modernization of Cosmetics Regulation Act (MoCRA). These important changes, affecting manufacturers, packers, and distributors, will become enforceable on December 29, 2023. Key points of the FDA’s update include: This update signifies a significant step in ensuring consumer

FDA’s New Reporting Standards for Cosmetic Adverse Events Read More »